172 related articles for article (PubMed ID: 36528541)
1. Automated deep brain stimulation programming based on electrode location: a randomised, crossover trial using a data-driven algorithm.
Roediger J; Dembek TA; Achtzehn J; Busch JL; Krämer AP; Faust K; Schneider GH; Krause P; Horn A; Kühn AA
Lancet Digit Health; 2023 Feb; 5(2):e59-e70. PubMed ID: 36528541
[TBL] [Abstract][Full Text] [Related]
2. Closed-loop programming using external responses for deep brain stimulation in Parkinson's disease.
Sasaki F; Oyama G; Sekimoto S; Nuermaimaiti M; Iwamuro H; Shimo Y; Umemura A; Hattori N
Parkinsonism Relat Disord; 2021 Mar; 84():47-51. PubMed ID: 33556765
[TBL] [Abstract][Full Text] [Related]
3. Directional versus ring-mode deep brain stimulation for Parkinson's disease: protocol of a multi-centre double-blind randomised crossover trial.
Brinke TRT; Jergas H; Sisodia V; Barbe MT; Odekerken VJJ; Verbaan D; Dijk JM; Bot M; Beudel M; van den Munckhof P; Schuurman PR; de Bie RMA
BMC Neurol; 2023 Oct; 23(1):372. PubMed ID: 37853327
[TBL] [Abstract][Full Text] [Related]
4. Multiple-source current steering in subthalamic nucleus deep brain stimulation for Parkinson's disease (the VANTAGE study): a non-randomised, prospective, multicentre, open-label study.
Timmermann L; Jain R; Chen L; Maarouf M; Barbe MT; Allert N; Brücke T; Kaiser I; Beirer S; Sejio F; Suarez E; Lozano B; Haegelen C; Vérin M; Porta M; Servello D; Gill S; Whone A; Van Dyck N; Alesch F
Lancet Neurol; 2015 Jul; 14(7):693-701. PubMed ID: 26027940
[TBL] [Abstract][Full Text] [Related]
5. StimFit-A Data-Driven Algorithm for Automated Deep Brain Stimulation Programming.
Roediger J; Dembek TA; Wenzel G; Butenko K; Kühn AA; Horn A
Mov Disord; 2022 Mar; 37(3):574-584. PubMed ID: 34837245
[TBL] [Abstract][Full Text] [Related]
6. Deep brain stimulation outcomes in patients implanted under general anesthesia with frame-based stereotaxy and intraoperative MRI.
Matias CM; Frizon LA; Nagel SJ; Lobel DA; Machado AG
J Neurosurg; 2018 Dec; 129(6):1572-1578. PubMed ID: 29372880
[TBL] [Abstract][Full Text] [Related]
7. Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trial.
Odekerken VJ; van Laar T; Staal MJ; Mosch A; Hoffmann CF; Nijssen PC; Beute GN; van Vugt JP; Lenders MW; Contarino MF; Mink MS; Bour LJ; van den Munckhof P; Schmand BA; de Haan RJ; Schuurman PR; de Bie RM
Lancet Neurol; 2013 Jan; 12(1):37-44. PubMed ID: 23168021
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes using ClearPoint interventional MRI for deep brain stimulation lead placement in Parkinson's disease.
Ostrem JL; Ziman N; Galifianakis NB; Starr PA; Luciano MS; Katz M; Racine CA; Martin AJ; Markun LC; Larson PS
J Neurosurg; 2016 Apr; 124(4):908-16. PubMed ID: 26495947
[TBL] [Abstract][Full Text] [Related]
9. Imaging-based programming of subthalamic nucleus deep brain stimulation in Parkinson's disease.
Waldthaler J; Bopp M; Kühn N; Bacara B; Keuler M; Gjorgjevski M; Carl B; Timmermann L; Nimsky C; Pedrosa DJ
Brain Stimul; 2021; 14(5):1109-1117. PubMed ID: 34352356
[TBL] [Abstract][Full Text] [Related]
10. Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease.
Liu Y; Li W; Tan C; Liu X; Wang X; Gui Y; Qin L; Deng F; Hu C; Chen L
J Neurosurg; 2014 Sep; 121(3):709-18. PubMed ID: 24905564
[TBL] [Abstract][Full Text] [Related]
11. Subthalamic nucleus deep brain stimulation with a multiple independent constant current-controlled device in Parkinson's disease (INTREPID): a multicentre, double-blind, randomised, sham-controlled study.
Vitek JL; Jain R; Chen L; Tröster AI; Schrock LE; House PA; Giroux ML; Hebb AO; Farris SM; Whiting DM; Leichliter TA; Ostrem JL; San Luciano M; Galifianakis N; Verhagen Metman L; Sani S; Karl JA; Siddiqui MS; Tatter SB; Ul Haq I; Machado AG; Gostkowski M; Tagliati M; Mamelak AN; Okun MS; Foote KD; Moguel-Cobos G; Ponce FA; Pahwa R; Nazzaro JM; Buetefisch CM; Gross RE; Luca CC; Jagid JR; Revuelta GJ; Takacs I; Pourfar MH; Mogilner AY; Duker AP; Mandybur GT; Rosenow JM; Cooper SE; Park MC; Khandhar SM; Sedrak M; Phibbs FT; Pilitsis JG; Uitti RJ; Starr PA
Lancet Neurol; 2020 Jun; 19(6):491-501. PubMed ID: 32470421
[TBL] [Abstract][Full Text] [Related]
12. Three-dimensional SPACE fluid-attenuated inversion recovery at 3 T to improve subthalamic nucleus lead placement for deep brain stimulation in Parkinson's disease: from preclinical to clinical studies.
Senova S; Hosomi K; Gurruchaga JM; Gouello G; Ouerchefani N; Beaugendre Y; Lepetit H; Lefaucheur JP; Badin RA; Dauguet J; Jan C; Hantraye P; Brugières P; Palfi S
J Neurosurg; 2016 Aug; 125(2):472-80. PubMed ID: 26745490
[TBL] [Abstract][Full Text] [Related]
13. CLOVER-DBS: Algorithm-Guided Deep Brain Stimulation-Programming Based on External Sensor Feedback Evaluated in a Prospective, Randomized, Crossover, Double-Blind, Two-Center Study.
Wenzel GR; Roediger J; Brücke C; Marcelino ALA; Gülke E; Pötter-Nerger M; Scholtes H; Wynants K; Juárez Paz LM; Kühn AA
J Parkinsons Dis; 2021; 11(4):1887-1899. PubMed ID: 34151855
[TBL] [Abstract][Full Text] [Related]
14. Relationship between electrode position of deep brain stimulation and motor symptoms of Parkinson's disease.
Zhang F; Wang F; Li W; Wang N; Han C; Fan S; Li P; Xu L; Zhang J; Meng F
BMC Neurol; 2021 Mar; 21(1):122. PubMed ID: 33731033
[TBL] [Abstract][Full Text] [Related]
15. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
[TBL] [Abstract][Full Text] [Related]
16. Differential Effects of Subthalamic Nucleus and Globus Pallidus Internus Deep Brain Stimulation on Motor Subtypes in Parkinson's Disease.
Fan S; Liu D; Shi L; Meng F; Fang H; Liu H; Zhang H; Yang A; Zhang J
World Neurosurg; 2022 Aug; 164():e245-e255. PubMed ID: 35489598
[TBL] [Abstract][Full Text] [Related]
17. The MDS-UPDRS tracks motor and non-motor improvement due to subthalamic nucleus deep brain stimulation in Parkinson disease.
Chou KL; Taylor JL; Patil PG
Parkinsonism Relat Disord; 2013 Nov; 19(11):966-9. PubMed ID: 23849499
[TBL] [Abstract][Full Text] [Related]
18. Ten-year outcome of subthalamic stimulation in Parkinson disease: a blinded evaluation.
Castrioto A; Lozano AM; Poon YY; Lang AE; Fallis M; Moro E
Arch Neurol; 2011 Dec; 68(12):1550-6. PubMed ID: 21825213
[TBL] [Abstract][Full Text] [Related]
19. Stimulation sites in the subthalamic nucleus and clinical improvement in Parkinson's disease: a new approach for active contact localization.
Garcia-Garcia D; Guridi J; Toledo JB; Alegre M; Obeso JA; Rodríguez-Oroz MC
J Neurosurg; 2016 Nov; 125(5):1068-1079. PubMed ID: 26848922
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes following awake and asleep deep brain stimulation for Parkinson disease.
Chen T; Mirzadeh Z; Chapple KM; Lambert M; Shill HA; Moguel-Cobos G; Tröster AI; Dhall R; Ponce FA
J Neurosurg; 2018 Mar; 130(1):109-120. PubMed ID: 29547091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
